IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 144 filers reported holding IDEAYA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,939,550 | +15.3% | 2,147,500 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $50,254,821 | +73.1% | 2,138,503 | +1.1% | 0.00% | +50.0% |
| Q1 2023 | $29,029,572 | -65.6% | 2,114,317 | -54.5% | 0.00% | 0.0% |
| Q4 2022 | $84,404,774 | +197.7% | 4,645,282 | +144.4% | 0.00% | 0.0% |
| Q3 2022 | $28,354,000 | +38.6% | 1,900,381 | +28.2% | 0.00% | +100.0% |
| Q2 2022 | $20,454,000 | -2.3% | 1,482,154 | -20.8% | 0.00% | 0.0% |
| Q1 2022 | $20,929,000 | -47.7% | 1,870,370 | +10.5% | 0.00% | -50.0% |
| Q4 2021 | $40,016,000 | +51.0% | 1,692,707 | +62.8% | 0.00% | +100.0% |
| Q3 2021 | $26,502,000 | +231.2% | 1,039,701 | +172.8% | 0.00% | – |
| Q2 2021 | $8,001,000 | +35.6% | 381,158 | +51.8% | 0.00% | – |
| Q1 2021 | $5,900,000 | +83.3% | 251,068 | +9.2% | 0.00% | – |
| Q4 2020 | $3,219,000 | +23.1% | 229,924 | +10.5% | 0.00% | – |
| Q3 2020 | $2,614,000 | +9.5% | 208,084 | +23.8% | 0.00% | – |
| Q2 2020 | $2,388,000 | – | 168,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |